xCT (SLC7A11)-mediated metabolic reprogramming promotes non-small cell lung cancer progression

zu Verbundenen Objekten

Standort
Deutsche Nationalbibliothek Frankfurt am Main
ISSN
1476-5594
Umfang
Online-Ressource
Sprache
Englisch
Anmerkungen
online resource.

Erschienen in
xCT (SLC7A11)-mediated metabolic reprogramming promotes non-small cell lung cancer progression ; day:23 ; month:5 ; year:2018 ; pages:1-13
Oncogene ; (23.5.2018), 1-13

Urheber
Ji, Xiangming
Beteiligte Personen und Organisationen
Qian, Jun
Rahman, S. M. Jamshedur
Siska, Peter J.
Zou, Yong
Harris, Bradford K.
Hoeksema, Megan D.
Trenary, Irina A.
Heidi, Chen
Eisenberg, Rosana
Rathmell, Jeffrey C.
Young, Jamey D.
Massion, Pierre P.
SpringerLink (Online service)

DOI
10.1038/s41388-018-0307-z
URN
urn:nbn:de:101:1-2018080122252228107047
Rechteinformation
Der Zugriff auf das Objekt ist unbeschränkt möglich.
Letzte Aktualisierung
15.08.2025, 07:36 MESZ

Datenpartner

Dieses Objekt wird bereitgestellt von:
Deutsche Nationalbibliothek. Bei Fragen zum Objekt wenden Sie sich bitte an den Datenpartner.
Original beim Datenpartner anzeigen

Beteiligte

  • Ji, Xiangming
  • Qian, Jun
  • Rahman, S. M. Jamshedur
  • Siska, Peter J.
  • Zou, Yong
  • Harris, Bradford K.
  • Hoeksema, Megan D.
  • Trenary, Irina A.
  • Heidi, Chen
  • Eisenberg, Rosana
  • Rathmell, Jeffrey C.
  • Young, Jamey D.
  • Massion, Pierre P.
  • SpringerLink (Online service)

Ähnliche Objekte (12)

METTL16 promotes glycolytic metabolism reprogramming and colorectal cancer progression

METTL16 promotes glycolytic metabolism reprogramming and colorectal cancer progression

LINE-1 promotes tumorigenicity and exacerbates tumor progression via stimulating metabolism reprogramming in non-small cell lung cancer

LINE-1 promotes tumorigenicity and exacerbates tumor progression via stimulating metabolism reprogramming in non-small cell lung cancer

Correction: METTL16 promotes glycolytic metabolism reprogramming and colorectal cancer progression

Correction: METTL16 promotes glycolytic metabolism reprogramming and colorectal cancer progression

LINC02159 promotes non-small cell lung cancer progression via ALYREF/YAP1 signaling

LINC02159 promotes non-small cell lung cancer progression via ALYREF/YAP1 signaling

Starvation induced autophagy promotes the progression of bladder cancer by LDHA mediated metabolic reprogramming

Starvation induced autophagy promotes the progression of bladder cancer by LDHA mediated metabolic reprogramming

Circular RNA circSATB2 promotes progression of non-small cell lung cancer cells

Circular RNA circSATB2 promotes progression of non-small cell lung cancer cells

Myc derived circRNA promotes triple-negative breast cancer progression via reprogramming fatty acid metabolism

Myc derived circRNA promotes triple-negative breast cancer progression via reprogramming fatty acid metabolism

BAP1 promotes osteoclast function by metabolic reprogramming

BAP1 promotes osteoclast function by metabolic reprogramming

SLIT3 deficiency promotes non-small cell lung cancer progression by modulating UBE2C/WNT signaling

SLIT3 deficiency promotes non-small cell lung cancer progression by modulating UBE2C/WNT signaling

NAT10/ac4C/FOXP1 Promotes Malignant Progression and Facilitates Immunosuppression by Reprogramming Glycolytic Metabolism in Cervical Cancer

NAT10/ac4C/FOXP1 Promotes Malignant Progression and Facilitates Immunosuppression by Reprogramming Glycolytic Metabolism in Cervical Cancer

Crotoxin promotes macrophage reprogramming towards an antiangiogenic phenotype

Crotoxin promotes macrophage reprogramming towards an antiangiogenic phenotype

Extracellular fibrin promotes non-small cell lung cancer progression through integrin β1/PTEN/AKT signaling

Extracellular fibrin promotes non-small cell lung cancer progression through integrin β1/PTEN/AKT signaling

Verbundene Objekte